Bevacizumab and Fotemustine for Recurrent Glioblastoma: A Phase II Study of AINO (Italian Association of Neuro-Oncology)
Journal of Neuro-Oncology - Netherlands
doi 10.1007/s11060-013-1317-x
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2013
Authors
Publisher
Springer Science and Business Media LLC